nach oben

Erschienen in:

01.03.2013 | Brief Communication

Locally Ablative Non-surgical Management of Colo-rectal Liver Metastasis

verfasst von: Amit Bahl, Rakesh Kapoor, Pramod Kumar Singh, Tapesh Bhattacharya, Oinam S. Arun, Tomar Parsee, Suresh C. Sharma

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Liver is one of the commonest sites of metastasis in colorectal cancer patients. Solitary liver metastasis or oligometastasis are traditionally treated by surgical resection or chemotherapy.

Discussion

There may be a subgroup of these patients who are not suitable for surgery or chemotherapy due to various co-morbid factors. These patients can be treated by novel minimally invasive or noninvasive ablative techniques like interstitial brachytherapy, extracranial stereotactic radiotherapy, and radiofrequency ablation.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRef

Steele G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer: biologic perspective. Ann Surg. 1989;210:127–38.PubMedCrossRef

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in ironotecan refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337–45.PubMedCrossRef

Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaloplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013–9.PubMedCrossRef

Van Custem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyns B, et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy refractory metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–34.CrossRef

Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawerence TS, Ten Haken RK, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–21.PubMedCrossRef

Ruhl R, Ludemann L, Czarnecka A, Streitparth F, Seidensticker M, Mohnike K, et al. Radiobiological restrictions and tolerance doses of repeated single-fraction HDR-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiat Oncol. 2010;5:44.PubMedCrossRef

Llovet JM, Sala M, Bruix J. Nonsurgical treatment of hepatocellular carcinoma. Liver Transpl. 2000;6:S11–5.PubMedCrossRef

Ricke J, Mohnike K, Pech M, Seidensticker M, Ruhl R, Weiners G, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2010;78:479–85.PubMedCrossRef

10.

Bahl A, Sharma DN, Basu J, Rath GK, Julka PK. Interstitial brachytherapy in liver metastasis. Ann Oncol. 2009;20:V18.CrossRef

11.

Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiotherapy of extracranial tumors using an accelerator. Clinical experience of first thirty one patients. Acta Oncol. 1995;34:861–70.PubMedCrossRef

12.

Goodman KA, Weigner EA, Maturen KE, Zhang Z, Mo Q, Yang G, et al. Dose-escalation study of single fraction stereotactic radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010;78:486–93.PubMedCrossRef

13.

Case RB, Moseley DJ, Sonke JJ, Eccles CL, Dinniwell RE, Kim J, et al. Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys. 2010;77:918–25.PubMedCrossRef

14.

Son SH, Choi BO, Ryu MR, Kang YN, Jang JS, Bae SH, et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose volumetric parameters predicting the hepatic complications. Int J Radiat Oncol Biol Phys. 2010;78:1073–80.PubMedCrossRef

15.

Murphy JD, Skieller CC, Kim J, Dietreich S, Chang DT, Koong AC. A dosimetric model for duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2010;78:1420–6.PubMedCrossRef

16.

Rosenthal DI, Hornicek FJ, Wolfe MW, Jennings LC, Gebhardt MC, Mankin HJ. Percutaneous radiofrequency coagulation of osteoid osteomas compared with operative treatment. J Bone Joint Surg Am. 1998;80:815–21.PubMed

17.

Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiotherapy. Cancer. 2002;94:443–51.PubMedCrossRef

18.

Noguchi M. Minimally invasive surgery for small breast cancer. J Surg Oncol. 2003;84:94–101.PubMedCrossRef

19.

Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141:181–90.PubMedCrossRef

20.

Larson TR, Bostwick DG, Corica A. A temperature correlated histopathological change following microwave thermoablation of obstructive tissues in patients with benign prostate hyperplasia. Urology. 1996;47:463–9.PubMedCrossRef

21.

Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493–508.PubMedCrossRef

22.

Rath GK, Julka PK, Thulkar S, Sharma DN, Bahl A, Bhatnagar S. Radiofrequency ablation of hepatic metastasis. Results of treatment in forty patients. J Cancer Res Ther. 2008;4:14–7.PubMedCrossRef

Titel: Locally Ablative Non-surgical Management of Colo-rectal Liver Metastasis
verfasst von: Amit Bahl
Rakesh Kapoor
Pramod Kumar Singh
Tapesh Bhattacharya
Oinam S. Arun
Tomar Parsee
Suresh C. Sharma
Publikationsdatum: 01.03.2013
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2013
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-012-9427-9

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Locally Ablative Non-surgical Management of Colo-rectal Liver Metastasis

Abstract

Background

Discussion

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Background

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Identification of Distinct Phenotypes of Locally Advanced Pancreatic Adenocarcinoma

Gastrointestinal Autonomic Nerve Tumor Presented as a Large Intraabdominal Abscess

Postoperative Radiotherapy in Periampullary Cancers: A Brief Review

Systemic Treatment of Gastrointestinal Cancer in Elderly Patients

Burden of Emergency and Non-emergency Colorectal Cancer Surgeries in West Virginia and the USA

Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality?

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie